Ameya Laboratories Ltd (532981) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 532981 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Ameya Laboratories

Based on:

M-Cap below 100cr DeciZen not available

Ameya Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
5.9 Cr.
52-wk low:
0.2
52-wk high:
0.3

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Ameya Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
ROCE % 0%21.7%37.8%45.2%52%48.2%24.5%17.6%15.3%11.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 026.362.790.3108150161204273268160
Sales YoY Gr.-NA138%44.1%19.4%39.5%6.9%27.2%33.4%-1.7%-
Adj EPS 00.10.10.40.81.10.70.90.70.2-0.8
YoY Gr.-NA180%178.6%112.8%31.3%-37.6%29.4%-25%-75.8%-
BVPS (₹) 00.40.50.923.15.86.46.56.7-1.5
Adj Net
Profit
00.52.15.713.21816.321.216.13.8-20
Cash Flow from Ops. 03.7-0.7-4.74.6-6.6-42.41328.5-10.1-
Debt/CF from Ops. 01.8-15.4-3.75.7-6.1-16.23.4-12.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA20%18.6%-1.7%
Adj EPS NA-28.1%-38.3%-75.8%
BVPSNA27.6%5.1%3.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
Return on
Equity %
011.833.654.658.843.216.513.8102.3-31.2
Op. Profit
Mgn %
07.59.312.12122.420.917.716.914.86.9
Net Profit
Mgn %
02.13.36.312.21210.210.45.91.4-12.4
Debt to
Equity
01.61.41.40.80.80.30.50.60.8-
Working Cap
Days
00111113126160271296221238227
Cash Conv.
Cycle
001124488916918214316985

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Ameya Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) -0.8 -
TTM Sales (₹ Cr.) 160 -
BVPS (₹.) -1.5 -
Reserves (₹ Cr.) -61 -
P/BV -0.16 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.23 / 0.25
All Time Low / High (₹) 0.17 / 28.57
Market Cap (₹ Cr.) 5.9
Equity (₹ Cr.) 24.5
Face Value (₹) 1
Industry PE 40.3

Management X-Ray of Ameya Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *52.9937.4245.1245.1265.9666.1269.8969.1674.8473.79
* Pledged shares as % of Promoter's holding (%)

Valuation of Ameya Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Ameya Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Sales26.3462.7090.32107.82150.41160.78204.46272.67268.04
Operating Expenses 24.3656.8679.4085.18116.76127.23168.22226.56228.49
Manufacturing Costs3.2112.8016.4316.1818.141716.6219.3020.07
Material Costs19.6640.5651.6459.4786.7295.26131.85180.07179.17
Employee Cost 0.711.321.662.432.793.315.229.5011.29
Other Costs 0.782.189.687.109.1111.6614.5417.6917.96
Operating Profit 1.985.8410.9222.6433.6533.5536.2446.1139.55
Operating Profit Margin (%) 7.5%9.3%12.1%21.0%22.4%20.9%17.7%16.9%14.8%
Other Income 0.860.170.671.353.991.562.260.060.58
Interest 1.522.723.234.788.347.4810.5916.5625.54
Depreciation 0.410.490.630.951.411.701.924.457.68
Exceptional Items 0000000-4.11-0.56
Profit Before Tax 0.922.797.7318.2727.9025.9325.9921.056.35
Tax 0.380.722.035.099.929.614.837.862.91
Profit After Tax 0.542.075.7013.1817.9816.3221.1713.193.44
PAT Margin (%) 2.1%3.3%6.3%12.2%12.0%10.1%10.4%4.8%1.3%
Adjusted EPS (₹)0.10.10.40.81.10.70.90.50.1
Dividend Payout Ratio (%)27%9%14%6%7%6%11%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12

Equity and Liabilities

Shareholders Fund 4.217.4012.6331.6551.63145.91161.03161.98165.42
Share Capital 0.971.305.197.988.2612.0824.1524.4524.45
Reserves 3.246.107.4423.6743.37133.83136.88137.53140.97
Minority Interest000000000
Debt6.6710.2417.5126.5140.6940.6581.1761.52110.37
Long Term Debt6.6710.2417.5126.5140.6940.6581.176.9237.68
Short Term Debt000000054.6072.69
Trade Payables7.7221.0612.7414.6013.3620.6322.186.435.99
Others Liabilities 1.792.484.627.7920.2917.0517.4460.9052.20
Total Liabilities 20.3841.1847.5080.53125.96224.23281.81290.84333.98

Fixed Assets

Gross Block8.839.0315.8624.0126.8732.8848.67117.26123.01
Accumulated Depreciation1.131.622.253.204.606.298.2123.4529.32
Net Fixed Assets 7.707.4113.6120.8222.2726.6040.4693.8293.69
CWIP 02.570.013.834.3317.0340.7621.9835.16
Investments 00.291.892.692.692.692.690.010.01
Inventories8.1617.9623.2834.5154.8170.2574.5069.1966.40
Trade Receivables3.509.565.107.2822.8462.0167.0155.1783.36
Cash Equivalents 0.050.420.151.781.263.574.536.803.56
Others Assets 0.972.973.469.6217.7642.0851.8743.8651.79
Total Assets 20.3841.1847.5080.53125.96224.23281.81290.84333.98

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Cash Flow From Operating Activity 3.66-0.67-4.684.62-6.62-42.3713.0328.46-10.13
PBT 0.462.095.7018.2727.9025.9325.9925.166.91
Adjustment 1.934.51-2.145.729.6310.7814.1820.9533.22
Changes in Working Capital 1.26-7.27-8.24-17.47-44.04-65.74-16.8-13.14-46.51
Tax Paid 000-1.89-0.10-13.34-8.84-5.83-3.19
Cash Flow From Investing Activity -1.78-3.07-5.87-12.76-3.23-18.73-39.51-22.60-18.93
Capex -1.80-2.77-4.27-11.98-3.36-18.73-39.51-22.60-18.93
Net Investments 0-0.29-1.60-0.8000000
Others 0.02000.020.130000
Cash Flow From Financing Activity -1.894.0910.289.769.3463.4027.44-3.7325.82
Net Proceeds from Shares 0.100.224.146.024.1080.22000
Net Proceeds from Borrowing 0008.9914.18007.2912.76
Interest Paid -1.5200-4.78-8.34-7.03-10.57-16.50-25.54
Dividend Paid -0.0500-0.47-0.61-1.81-2.26-2.420
Others -0.423.876.1400-7.9840.277.9038.61
Net Cash Flow -0.010.36-0.271.63-0.522.310.962.13-3.23

Finance Ratio

PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Ratios
ROE (%)12.9535.8357.2359.7343.2417.0814.48.432.13
ROCE (%)21.6737.8445.1551.9548.1924.5317.5915.3311.6
Asset Turnover Ratio1.482.292.271.881.621.010.861.020.9
PAT to CFO Conversion(x)6.78-0.32-0.820.35-0.37-2.60.622.16-2.94
Working Capital Days
Receivable Days4234271933871087790
Inventory Days99687587971291219088
Payable Days143130119845965592913

Ameya Laboratories Ltd Stock News

Ameya Laboratories Ltd FAQs

The current trading price of Ameya Laboratories on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ameya Laboratories stood at ₹5.87.
The latest P/E ratio of Ameya Laboratories as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Ameya Laboratories as of 31-Dec-1969 is -0.16.
The 52-week high of Ameya Laboratories is ₹0.25 and the 52-week low is ₹0.23.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ameya Laboratories is ₹160.3 ( Cr.) .

About Ameya Laboratories Ltd

Anu's Laboratories is an ISO 9001:2000 certified company established in 1996, engaged in the manufacture of quality drug intermediates to meet the needs of international customers. The optimized process of 2, 4- Dichloro- 5 Fluoro Acetophenone has enabled the brand to establish itself as the flagship product of the organization. It is available to its wide customer base as a competitive product of the highest quality. Other high quality intermediates such as Chlorohexanone, 1, 3-Dibromo Propane are also available to its valued customers. The company is also producing Methyl- 4 (4-Chloro 1 oxo butyl), a Di-Methyl Acetate. Its state-of-the-art R&D facilities, located at Balanagar, Hyderabad, support the process of product development, contract research and customised synthesis programmes of the organization.

The company has entered into a job work agreement with Nitya Laboratories for manufacture of Sodium Methoxide or Sodium Methylate Solution and Powder and CIS (+) Hydroxide Lactum. Nitya Laboratories is one of the promoter group company involved in the manufacturing of fine chemicals and intermediates.

In 2010  Anu's Laboratories acquired Stilbene Chemicals Ltd.

Products

  • Basic Intermediates
  • Advanced Intermediates
  • Fine Chemicals
  • Products in pipeline

Achievements

  • The company received the state level Best SSI Entrepreneur Award for the year 2001-02 from the AP state government. 
  • The company was awarded the Market Penetration Leadership in the Indian Pharmaceutical Intermediates Market by M/s Frost & Sullivan for the year 2005.
  • Consistent and long-term relationship with customers.
  • Developed ‘A Cleaner Production Process’ by recovering by-products of commercial value from waste water.
  • Challenged the Chinese monopoly & attained leadership position in many of its products.
  • Developed and commercialized new intermediates; many more in pipeline.
  • ISO 9001 and Q9001-2000 Certifications.
  • Anu's R&D recognized by Department of Scientific and Industrial Research (DSIR), Government of India, New Delhi.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×